SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : The Financial Collapse of 2001 Unwinding

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Elroy Jetson who wrote (8336)12/18/2021 1:50:03 AM
From: elmatador  Read Replies (2) of 13801
 
CDC narrows use of J&J vaccine due to concerns about rare blood clots
The Centers for Disease Control and Prevention accepted advice from a panel of experts to recommend the use of the Moderna and Pfizer-BioNTech COVID-19 vaccines over the Johnson & Johnson jab, following growing concerns about rare blood clots.

https://www.npr.org/sections/coronavirus-live-updates/2021/12/16/1064909742/cdc-vote-narrow-use-of-johnson-and-johnson-covid-vaccine

Rare blood clots. That not to scare the shit out of the peopole who was hereded into get J&J vaccine.

This is only the beginning. Unfortunately more will come.



How about that big stock of J&J vaccines?
Donation to Africa, Caribbean and S. E. Asian. Charity Elroy.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext